By cutting in half the activity of a gene, scientists corrected many symptoms of a genetic defect in mice analogous to fragile X syndrome, a leading cause of inherited mental retardation in people.
The research suggests a new target for drug therapy for the condition, which is currently untreatable. However, it remains uncertain whether such drugs would benefit adults who have the disease.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.